Fidelity Investments
BBH icon

Fidelity Investments’s VanEck Biotech ETF BBH Stock Holding History

Fidelity Investments’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Sell
1,603
-2
-0.1% -$376 ﹤0.01% 3470
2026
Q1 		$302K Buy
1,605
+554
+53% +$107K ﹤0.01% 3317
2025
Q4 		$199K Buy
1,051
+520
+98% +$96.2K ﹤0.01% 3441
2025
Q3 		$87.9K Buy
531
+199
+60% +$32.4K ﹤0.01% 3720
2025
Q2 		$50.9K Buy
332
+3
+0.9% +$447 ﹤0.01% 3895
2025
Q1 		$51.8K Sell
329
-53
-14% -$8.6K ﹤0.01% 3846
2024
Q4 		$59.9K Sell
382
-30
-7% -$5.05K ﹤0.01% 3761
2024
Q3 		$73K Buy
412
+39
+10% +$6.92K ﹤0.01% 3607
2024
Q2 		$62.8K Buy
373
+33
+10% +$5.4K ﹤0.01% 3498
2024
Q1 		$56.6K Buy
340
+170
+100% +$28.1K ﹤0.01% 3524
2023
Q4 		$28K Buy
170
+61
+56% +$9.39K ﹤0.01% 3779
2023
Q3 		$16.9K Hold
109
– – ﹤0.01% 3891
2023
Q2 		$17K Sell
109
-67
-38% -$10.7K ﹤0.01% 3939
2023
Q1 		$28.6K Sell
176
-35
-17% -$5.66K ﹤0.01% 3685
2022
Q4 		$33.6K Buy
211
+177
+521% +$28K ﹤0.01% 3583
2022
Q3 		$5K Sell
34
-2
-6% -$302 ﹤0.01% 4293
2022
Q2 		$5K Sell
36
-73
-67% -$10.9K ﹤0.01% 4297
2022
Q1 		$18K Sell
109
-15
-12% -$2.43K ﹤0.01% 4043
2021
Q4 		$23K Buy
124
+4
+3% +$771 ﹤0.01% 3420
2021
Q3 		$24K Buy
120
+54
+82% +$11.3K ﹤0.01% 3383
2021
Q2 		$13K Buy
66
+13
+25% +$2.42K ﹤0.01% 3480
2021
Q1 		$9K Sell
53
-57
-52% -$10.3K ﹤0.01% 3400
2020
Q4 		$18K Buy
110
+23
+26% +$3.79K ﹤0.01% 3197
2020
Q3 		$14K Sell
87
-62
-42% -$10.1K ﹤0.01% 3128
2020
Q2 		$24K Sell
149
-228
-60% -$34.6K ﹤0.01% 2946
2020
Q1 		$48K Buy
377
+76
+25% +$10.2K ﹤0.01% 2778
2019
Q4 		$42K Sell
301
-141
-32% -$18.5K ﹤0.01% 2933
2019
Q3 		$52K Buy
442
+342
+342% +$42.5K ﹤0.01% 2852
2019
Q2 		$13K Hold
100
– – ﹤0.01% 3170
2019
Q1 		$13K Buy
100
+99
+9,900% +$12.5K ﹤0.01% 3065
2018
Q4 		$0 Buy
+1
New +$121 ﹤0.01% 3522

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments's BBH Position: Q2 2026 in Review

Fidelity Investments reduced its VanEck Biotech ETF (BBH) stake by 0.12% in Q2 2026, selling an estimated $376 and leaving 1,603 shares worth $326K. The position accounts for ﹤0.01% of the portfolio, ranked #3470.

Fidelity Investments first reported a position in BBH in Q4 2018 and has held it in 31 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Fidelity Investments held 1,603 shares of VanEck Biotech ETF worth $326K as of Q2 2026.
  • Fidelity Investments sold 2 VanEck Biotech ETF shares in Q2 2026, an estimated $376.
  • VanEck Biotech ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3470 holding.
  • Fidelity Investments first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 31 quarters since.
  • 110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.